rss Posted October 24, 2013 Report Share Posted October 24, 2013 [Off-label indications for topical tacrolimus]. Hautarzt. 2013 Oct;64(10):752-6 Authors: Hengge UR Abstract The topical calcineurin antagonist tacrolimus plays an important role in the treatment of different forms of eczema because of its favorable risk profile. In addition, different off-label indications have been clinically tested where tacrolimus ointment has achieved clinical improvement. This article discusses off-label treatment of vitiligo, seborrheic dermatitis, steroid rosacea, perioral dermatitis, rosacea and lichen sclerosus. PMID: 24150824 [PubMed - in process] http://www.ncbi.nlm.nih.gov/pubmed/24150824?dopt=Abstract = URL to article Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.